Clinical Trial Applications: Filter, Search, and view applications


Clear
Extended search...

Page 20 of 89, showing 5 Applications out of 442 total, starting on record 96, ending on 100

# Protocol No Study Title Investigator(s) & Site(s)

96.

ECCT/15/10/03   Safer Conception Intervention for Partners (SCIP)
    Pilot of an mHealth-enhanced, safer conception intervention to reduce HIV-1 risk among Kenyan HIV-1 serodiscordant couples   Safer Conception Intervention for Partners (SCIP)   
Principal Investigator(s)
1. Nelly Rwamba Mugo
Site(s) in Kenya
Thika Partners Study Clinic (Partners in Health Research and Development) affiliated to the University of Washington International Clinical Research Center (ICRC), and KEMRI
 
View

97.

ECCT/21/09/02   PrEDIRA - 2
    Piloting HIV Pre-exposure Prophylaxis (PrEP) Integration into Services for Early Pregnancy Loss   
Principal Investigator(s)
1. Nelly Rwamba Mugo
Site(s) in Kenya
1. KEMRI-CCR PHRD THIKA - Thika, Nairobi, Murang\'a, and their environs (Kiambu county)
2. Kisumu clinical trial site - Kisumu and its enrvirons (Kisumu county)
3. Mariestopes - Nairobi (Nairobi City county)
 
View

98.

ECCT/19/11/05   Point-of-care Urine Monitoring of Adherence (PUMA)
    Point-of-care Urine Monitoring of Adherence (PUMA): Testing a Real-Time Urine Assay of Tenofovir in PrEP   Pilot trial to examine the feasibility, acceptability and impact on longer-term adherence of an intervention using a new urine-based tenofovir adherence assay       
Principal Investigator(s)
1. Nelly Rwamba Mugo
Site(s) in Kenya
KEMRI-CCR PHRD (THIKA) PROJECT
 
View

99.

ECCT/12/11/01  
    Prospective Observational Study of Male Circumcision Using   the PrePex Device in Routine Clinical Settings in Kenya   
Principal Investigator(s)
1. Robert Bailey
2. Peter Cherutich
3. Walter Obiero
4. Elijah Odoyo June
Site(s) in Kenya
The Nyanza Reproductive Health Society UNIM clinic in Kisumu with assistance from NRHS’s mobile outreach service providers in Rachuonyo.
 
View

100.

ECCT/23/05/01   A5356
    A Phase II, Prospective, Randomized, Multicenter Trial to Evaluate the Efficacy and Safety/Tolerability of Two Linezolid Dosing Strategies in Combination with a Short Course Regimen for the Treatment of Drug-Resistant Pulmonary Tuberculosis   
Principal Investigator(s)
1. Abraham Mosigisi Siika
Site(s) in Kenya
MOI UNIVERSITY CLINICAL RESEARCH CENTRE
 
View